Omega-3 supplements and antioxidants may help with preclinical Alzheimer's disease

Posted on July 1, 2015

A new report published in the July 2015 issue of The FASEB Journal describes the findings of a very small study in which people with mild clinical impairment, such as those in the very early stages of the disease, saw clearance of the hallmark amyloid-beta protein and reduced inflammation in neurological tissues.

Although the findings involved just 12 patients over the course of 4 to 17 months, the findings suggest further clinical study of this relatively inexpensive and plentiful supplement should be conducted.

“We’ve known for a long time that omega-3 fatty acids and some antioxidants can be beneficial to people with a wide range of health problems, as well as protective for healthy people,” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “Now, we know that the effects of these supplements may extend to Alzheimer’s disease as well. Although these supplements are considered to be generally safe and are very easy to obtain, full-scale clinical trials are necessary to verify the findings of this research and to identify who might benefit the most.”

To read the full article, click on the link below.

Category(s):Adult psychological development

Source material from PsyPost

Mental Health News

  • Human-Centered Approach for Dementia Patients

    newsthumbA group of researchers recently conducted a randomized controlled trial to evaluate the impact of applying a human rights based approach in dementia ...

  • 6 Signs of a Codependent Relationship

    newsthumbCodependency can be recognised when two people with dysfunctional traits become worse together. The biggest issue is the belief by one or both ...

  • ODD and the Rebellious Child

    newsthumbOppositional Defiant Disorder (ODD), while exhibiting symptoms that sound very much like a typical rebellious child's behavior, is a disorder that ...